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Background: Chronic diseases may influence patients taking major life changing decisions (MLCDs) concerning for
example education, career, relationships, having children and retirement. A validated measure is needed to evaluate
the impact of chronic diseases on MLCDs, improving assessment of their life-long burden. The aims of this study
were to develop a validated questionnaire, the “Major Life Changing Decision Profile” (MLCDP) and to evaluate its
psychometric properties.
Methods: 50 interviews with dermatology patients and 258 questionnaires, completed by cardiology,
rheumatology, nephrology, diabetes and respiratory disorder patients, were analysed for qualitative data using
Nvivo8 software. Content validation was carried out by a panel of experts. The first version of the MLCDP was
completed by 210 patients and an iterative process of multiple Exploratory Factor Analyses and item prevalence
was used to guide item reduction. Face validity and practicability was assessed by patients.
Results: 48 MLCDs were selected from analysis of the transcripts and questionnaires for the first version of the MLCDP,
and reduced to 45 by combination of similar themes. There was a high intraclass correlation coefficient (0.7) between
the 13 members of the content validation panel. Four more items were deleted leaving a 41-item MLCDP that was
completed by 210 patients. The most frequently recorded MLCDs were decisions to change eating habits (71.4%), to
change smoking/drinking alcohol habits (58.5%) and not to travel or go for holidays abroad (50.9%).
Factor analysis suggested item number reduction from 41 to 34, to 29, then 23 items. However after taking into
account item prevalence data as well as factor analysis results, 32 items were retained. The 32-item MLCDP has five
domains education (3 items), job/career (9), family/relationships (5), social (10) and physical (5). The MLCDP score is
expressed as the absolute number of decisions that have been affected.
Conclusions: The 32-item (5 domains) MLCDP has been developed as an easy to complete generic tool for use in
clinical practice and for quality of life and epidemiological research. Further validation is required.
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The focus of health-related quality of life (HRQoL) re-
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reproduction in any medium, provided the orlife changing decisions (MLCDs) [1,2], such as those
concerning education, career, relationships or having
children [3-7].
There is little information available about the impact
of chronic diseases on MLCDs and there has been no
defined measure to capture this information [1]. There
are many published surveys assessing the impacts of
chronic diseases on patients’ HRQoL. However, these
studies have not addressed the long term impact of
chronic disease on critical life decisions taken by pa-
tients [1]. Instruments to measure HRQoL usually assesstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sess the long term impact of disease, which may change
over time. Even follow up studies, which might be
expected to encompass more long term issues, usually
compare current impacts before and after. In our review
of HRQoL instruments we could not identify any instru-
ment containing items to capture the influence of
chronic disease on MLCDs or any long term impact on
patients’ lives [1].
A method to measure this impact is needed to draw
attention to the issues, to identify specific patient needs,
to allow a more complete assessment of the burden of
disease and to permit comparison between the impacts
of different diseases; with timely identification of the
needs of patients, appropriate intervention may enable
patients with chronic conditions to fulfil their full poten-
tial and aspirations. The aim of this study was to develop
a standardised tool for use across all chronic conditions
to record the influence of chronic disease on MLCDs
and initially validate such a measure.
Methods
The South East Wales Research Ethics Committee ap-
proved this cross-sectional prospective study on 2nd June
2008. All participants gave informed written consent.
Study participants
Patients (aged 16 years and above) who had had chronic
disease for > 1 year were recruited from the outpatient
departments of dermatology, cardiology, rheumatology,
nephrology, diabetes and respiratory disorders at the
University Hospital of Wales, Cardiff and University
Hospital Llandough. Patients were excluded if suffering
from other illness or disability.
Data processing and analysis
Data was processed using SPSS16 statistical software for
Windows. Descriptive statistics were used to record the
judges' responses (%) on a four point scale. Statistically,
Kappa coefficient and intraclass correlation coefficient
(ICC) techniques were used to evaluate the agreement
among the panel of judges for inter-rater reliability. For
non-quantitative data (categorical/nominal), the kappa
coefficient is the technique of choice. The ICC is more
appropriate and better than the kappa technique for
analysing data obtained from ratings using any scale
(e.g. from 1 to 10) [8,9].
The level of agreement among the panel members for
each item of the MLCDP was assessed statistically by
using ICC for the quantitative and kappa technique for
the qualitative phase to measure the level of agreement
(inter-rater reliability) among the panel of judges. The
SPSS software generally provides kappa statistics for only
two judges. The Cohen Kappa macro syntax file wascomputed using SPSS12 software to calculate the mul-
tiple inter-rater agreement (>2 raters).
Procedure
There were four stages; conceptualisation and item gener-
ation, item reduction and development of the first version
of a new tool, content validity and development of a re-
vised version and construct validation using factor ana-
lysis. Using a formal check list [10], we conceptualised the
development of a self-administered general health profile
with multi-dichotomous close-ended simple statements.
Data for item generation were collected from a postal
survey and individual interviews. Core themes and cat-
egories were identified using content analysis [3-7], and a
generic MLCD questionnaire was developed, the “Major
Life Changing Decisions Profile” (MLCDP). NVivo 8 and
SPSS16 software were used.
The items generated were analysed using standard quali-
tative strategies [10-12] to reduce them to the core items
identified from the interview transcripts. Some population
and gender specific items were retained. After qualitative
analysis, taxonomy techniques and rephrasing of items/
statements were introduced to fit the items into categories.
Standard methods [10] to assess and modify language,
reading age and item lengths were applied.
The 45-item MLCDP (version 1) was content validated
by a team of experts (panel of judges). Their task was to
review the profile, rate each item and to suggest appro-
priate changes to develop a profile that could accurately
measure what it was intended to measure, with appro-
priate focus and emphasis for the target population.
Consultant physicians, specialist nurses and academic
experts from different disciplines were invited to join the
panel of judges and to take part in this process. The
content validation process was carried out in two phases,
quantitative assessment and qualitative assessment.
For quantitative assessment, the MLCDP (version 1) and
the questionnaire items rating sheets were sent out to the
panel of judges to rate each item and for their expert opin-
ion. The members of the panel were asked to bring their
items rating sheets for discussion at the subsequent meeting.
Instruction was provided for rating of the MLCDP (version
1) on a four point Likert type ordinal scale (1 = Strongly
agree, 2 =Agree, 3 =Disagree and 4 = Strongly disagree) for
each of the four criteria of language clarity, completeness,
scaling and relevance. Under each item, a separate section
was provided for the judges to write any suggestions.
In the qualitative assessment stage, all 13 panel mem-
bers returned their completed item rating sheets and 6
panel members attended the discussion. The discussion
was digitally recorded for later analysis. During the meet-
ing, patients’ comments given at the conceptualisation
stage were consulted again where necessary to clarify the
discussion. Various changes were made with consensus to
Table 1 Initial MLCD domains with main categories of
decision types
A. Education
Education
B. Career/Work
Career choice
Early retirement
Job
Professional bodies
Professional sports
C. Family/Relationships
Having children
Relationships
D. Social
Lifestyle (smoking, drinking alcohol)
Holidays/travel abroad
Housing
Move abroad
Move city
Clothing
Swimming
Not socialise
Make up
E. Physical
Sports
Driving
F. Major treatment decisions
Dialysis
Organ transplant
Surgery
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and sequence) to reduce ambiguity and to make the
MLCDP simpler, more user friendly and easier to
understand.
This revised MLCDP was administered to another co-
hort of subjects for further construct validation using
the Exploratory Factor Analysis technique of “principle
component analysis” [13]. A correlation and component
matrix was created for the assessment of data suitability
followed by application of the Kaiser-Meyer-Olkin
(KMO) measure and Bartlett’s test of sphericity for ad-
equate sampling. For factor extraction, Kaiser’s criterion
and Cattell’s scree test were carried out and the varimax
technique was used for factor rotation and final inter-
pretation. Cronbach’s alpha statistics were used to meas-
ure internal consistency [14].
Face validity and practicality of the new tool was
assessed by using a separate simple tick box question-
naire to record patients’ views on the new tool and by
measuring time required to complete the MLCDP.
Results
655 patients were invited to take part, of whom 365
(55.7%) responded. There were 308 (83.7%) evaluable re-
sponses (postal survey = 258, individual interviews = 50).
The disease duration of these subjects ranged from
2–61 years (median = 18). The frequency and percentage
of the emerged MLCD themes have been previously
reported [3-7].
Domain generation
15 main MLCD categories and some individual items
were identified (3–7) and initially grouped under six
MLCD domains, namely: “education”, “career/work”,
“family/relationships”, “social”, “physical” and “major
treatment decisions” (Table 1).
Item/Statement generation
The survey responses and interview transcriptions were
cross-referenced during the decision-making process of
using the themes for construction generation of each
item. Items were kept short and phrased in the past
tense. The core MLCD domains and statements were ar-
ranged sequentially to reflect life stages.
Two non-MLCD “life style” issues “to take part in other
sports activities” and “to give up driving” were grouped
under the “physical” domain. The items related to “com-
munity activities” and to “wear a wig/toupee” were in-
cluded in the “social” domain. The gender specific MLCD
“wearing make up” was addressed separately.
Item reduction
Initially, 48 items/statements were generated. Statements
considered inappropriate, ambiguous or not universalwere deleted. Several items were rephrased or combined.
Items mentioned by less than 5% of respondents were
not included.
The theme “not to mention illness on job application”
was removed as this was considered an inappropriate ac-
tion. The theme “not to seek employment” was removed
because of similarity with another theme. One independ-
ent main category “to quit from professional sports” was
excluded as it was reported by <5% of the patients. How-
ever some gender and speciality specific categories were
retained, such as “major treatment decisions” and “to
wear make up”. The statement, “To leave a professional
association/committee” was retained because of its gen-
eric nature. One life style MLCD related to “swimming”
was put under the “social” rather than the “physical” do-
main: it was only reported by patients who were suffer-
ing from skin conditions, but this item may also be of
relevance to patients with physical conditions. Another
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ities” was added to the “physical” domain.Development of the draft MLCDP
The resulting 45-item draft profile covered six MLCD
domains related to education (4 items), career/work (13
items), family/relationships (8 items), social (16 items),
physical (3 items) and major treatment decisions
(1 item). A 4-point (5 response options) unipolar “adjec-
tival” scale (No influence = 0, Slight influence = 1, Mod-
erate influence = 2, Strong influence = 3 and A very
strong influence = 4) was initially adopted for the
MLCDP [10].
In the designing of the MLCDP we decided that we
wished to measure the total impact of all of a patient’s
health conditions rather than focus on the effect of one
specific disease. The reason for this is that if a patient
has more than one condition affecting MLCDs, then it is
highly likely that both conditions would influence in dif-
ferent additive ways these decisions and it would often
be artificial to ask a patient to try to specify which
MLCD was influenced by a specific disease.Psychometric evaluation: content validity
The 45-item MLCDP was presented to a panel of experts
for content validation [10,15]. The 13 panel members in-
cluded clinicians from seven participating medical special-
ities: seven consultant physicians (5 males, 2 females) and
six specialist nurses (all female). Eleven panel members
were independent from the research team. Each panel
member rated each of the 45 items on a 4-point scale
(strongly agree to strongly disagree) for each of the four
criteria, language clarity, completeness, scaling and rele-
vance and suggested changes where they identified issues
with any of these criteria. For each criterion, the percent-
age of panel members that strongly agreed, agreed, dis-
agreed and strongly disagreed with that criterion having
been fulfilled was calculated (Table 2).
The median values of the panel members’ ratings indi-
cated good agreement between them in all four criteria
(Table 2). The items that did not gain agreement across
all four criteria were “I decided not to take promotion”,Table 2 Responses from the expert panel
Response
option
Frequency of panel members’ ratings across four
criteria of the 45 items (%)
Language clarity Relevance Completeness Scaling
Strongly agree 58 55 50 57
Agree 28 33 33 28
Disagree 12 9 13 13
Strongly disagree 2 3 4 2
For each criterion the percentage is given of the 13 panel members agreeing
with that criterion being fulfilled.“I decided to stay in the same employment”, “I decided
to leave a professional association/committee” and “I de-
cided not to go swimming”. The following items failed
on three criteria: “I decided to change my choice of car-
eer”, “I decided to give up a job”, “I decided to have IVF
(In Vitro Fertilisation) treatment”, and “I decided to
change my eating habits”.
The Intraclass Correlation Coefficient (ICC) analysis of
absolute agreement showed an ICC of 0.707 (p = <0.0001;
CI = 0.61 to 0.78) [8] indicating good inter-rater reliability
among the panel and supporting the content validation.
Four clinicians (2 males, 2 females) and two academic
QoL experts (both male), took part in the subsequent
qualitative panel discussion. Each item was discussed
until consensus was reached on their retraction, addition
or modifications. The panel members’ responses had a
Cohen’s Kappa [8] value for multiple raters (n = 6) of
0.81, (p = <0.0001, CI = 0.69 to 0.93). This value indicates
“almost perfect agreement” [16] among the panel mem-
bers on the 45 items, further supporting the content val-
idity of the MLCDP.
Changes were implemented to produce the 41-item
MLCDP. The six MLCD domains were reduced to five:
education (4 items), job/career (10 items), family/relation-
ships (7 items), social (15 items) and physical (5 items).
This revised version was then examined by factor analysis.
Factor analysis
225 patients were invited by post to complete the 41-
item MLCDP: 15(6.6%) declined. 210 (93.3%) patients
(30 from each of the seven specialities, with 32 different
chronic conditions, mean disease duration = 19 yrs
(range 2–74) (Tables 3 and 4) completed the 41-item
MLCDP. The MLCDP was printed on thick blue paper
to increase the response rate [17]. All 210 patients an-
swered all of the items.
The internal consistency of the 41-item MLCDP mea-
sured by Cronbach’s alpha was 0.84, indicating good reliabil-
ity [18]. Seven items had corrected total-item correlations of
<0.2 and were removed, increasing the Cronbach’s alpha of
the 34-item MLCDP to 0.85 (Appendix 1).
Exploratory factor analysis of the 34-item MLCDP was
used to determine its construct validity [13] and to re-
duce the number of items if necessary [18,19] (Tables 5
and 6, Figure 1). Items that failed to load on any compo-
nent or had a weak loading were removed, reducing the
item number to 29 (Appendix 1).
Factor analysis was carried out on this 29-item MLCDP
to determine whether the remaining items fitted well
under the appropriate domains (Table 7, Figure 2). This
suggested that a further 6 items could be deleted, reducing
the MLCDP to 23 items (Appendix 1).
In order to ensure that all perspectives were consid-
ered in the decisions relating to retention and deletion
Table 3 Socio-demographic characteristics of the study
participants (n = 210)
Variables Number (%)
Age (years)
Minimum-Maximum 16-89
Median 52
Mean 50.8
Gender
Female 108 (51.4)
Male 102 (48.6)
Education
School 122 (58.1)
College 52 (24.8)
University 36 (17.1)
Marital status
Single/Divorced/Widowed 98 (46.6)
Married/Living with partner/Civil partnership 112 (53.4)
Employment status
Employed/Self employed 77 (36.7)
Unemployed 42 (20)
Retired/Early retirement 88 (41.9)
Housewife/Student 3 (1.4)
Table 4 Prevalence of different disease states in the
study participants (n = 210)
Specialities/diseases N Percent
1. Cardiology
Coronary artery disease 7 3.3
Congenital heart disease 12 5.7
Atrial fibrillation 6 2.9
Myocardial infarction 3 1.4
Congestive pericarditis 1 0.5
Congestive heart failure 1 0.5
2. Nephrology
Chronic Kidney Disease IV 23 11.0
Chronic Kidney Disease V 7 3.3
3. Respiratory Medicine
Chronic Obstructive Pulmonary Disease 30 14.3
4. Cystic Fibrosis 30 14.3
5. Diabetes
Diabetes Type 2 23 11.0
Diabetes Type 1 7 3.3
6. Rheumatology
Rheumatoid arthritis 12 5.7
Ankylosing spondylitis 1 0.5
Psoriatic arthritis 6 2.9
Osteoarthritis 1 0.5
Polymyalgia rheumatica 1 0.5
Systemic lupus erythematosus 2 1.0
Sjorgen’s syndrome 1 0.5
Reflex sympathetic dystrophy 1 0.5
Connective tissue disorder 1 0.5
Sarcoidosis 1 0.5
Antiphospholipid syndrome 1 0.5
Fibromyalgia 1 0.5
Reflex sympathetic dystrophy 1 0.5
7. Dermatology
Psoriasis 16 7.6
Atopic eczema 8 3.8
Acne 2 1.0
Hidradenitis suppurativa 1 0.5
Alopecia areata 1 0.5
Pityriasis lichenoides chronica 1 0.5
Behcet’s syndrome 1 0.5
Total 210 100.0
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MLCDP was also carried out. This analysis suggested
that 11 items be deleted: these were compared with the
18 items suggested for deletion by the factor analysis of
the 32-item MLCDP (Table 8). Nine of these were the
same, supporting the strength of the initial analysis
(Appendix 1).
Scale refinement
The prevalence of deleted items reported in the qualita-
tive phase of the study was examined to assess the ap-
propriateness of reinstating any removed items and to
assist item merger decisions. Final decisions on item de-
letion, rephrasing or regrouping were made on the basis
of the factor analyses, on item prevalence and on statis-
tical, conceptual and philosophical grounds.
An item ranking table was used to compare the lowest
ranked items with the items deleted as a result of factor
analyses. If an item did not conceptually belong to a spe-
cific component, this also informed the decision whether
or not to retain, remove or move that item to a more
relevant component.
The level of disease influence on MLCDs was evalu-
ated according to the percentage of patients who
reported this influence. Items were ranked according to
their prevalence (%) (Table 9). Only 16 items had a
prevalence of <10%. The top three affected MLCD itemsreported by patients were related to life style and were
placed in the social category: item D1. I decided to
change my eating habits, 71.4%; item D2. I decided to
change my smoking/drinking alcohol habits, 58.5%; and
item D3. I decided not to travel or go for holidays
abroad, 50.9%. Of the 18 items suggested for deletion as
Table 5 34-item MLCDP principle component analysis describing the total variance
Component Initial Eigenvalues Extraction Sums of Squared Loadings
Total % of Variance Cumulative % Total % of Variance Cumulative %
1 6.23 18.33 18.33 6.23 18.33 18.33
2 2.73 8.04 26.38 2.73 8.04 26.38
3 2.32 6.82 33.20 2.32 6.82 33.20
4 1.79 5.28 38.48 1.79 5.28 38.48
5 1.63 4.80 43.29 1.63 4.80 43.29
6 1.49 4.39 47.68 1.49 4.39 47.68
7 1.39 4.10 51.78 1.39 4.10 51.78
8 1.25 3.70 55.48 1.25 3.70 55.48
9 1.19 3.52 59.01 1.19 3.52 59.01
10 1.13 3.34 62.35 1.13 3.34 62.35
11 1.10 3.25 65.61 1.10 3.25 65.61
12 1.02 2.99 68.61 1.02 2.99 68.61
13 .93 2.74 71.35
14 .81 2.40 73.76
15 .80 2.37 76.12
16 .76 2.25 78.38
17 .70 2.06 80.44
18 .64 1.90 82.35
19 .59 1.73 84.08
20 .55 1.62 85.71
21 .53 1.57 87.28
22 .47 1.39 88.68
23 .46 1.36 90.04
24 .43 1.28 91.33
25 .41 1.22 92.55
26 .38 1.13 93.69
27 .35 1.04 94.74
28 .31 .92 95.67
29 .29 .85 96.52
30 .28 .83 97.35
31 .25 .73 98.09
32 .23 .70 98.79
33 .22 .65 99.44
34 .18 .55 100.00
Extraction Method: Principal Component Analysis.
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(with internal consistency reliability testing), 10 had a
prevalence of >10%. Of the 11 items suggested for dele-
tion as a result of factor analysis of the 41-item MLCDP
(without internal consistency reliability testing), 6 had a
prevalence of >10%: three of these items were first, sec-
ond and fourth in the prevalence ranking (Table 10).
This information was considered in the final selection of
the MLCDP items.Synthesis of the factor analysis findings
A strategy of item deletion, merger and application of
appropriate phraseology was adopted for scale refine-
ment. All 41 items were reviewed, with more attention
given to those items with a prevalence of <10% and
which were also suggested by one of the factor analyses
to be removed (Table 10). On the basis of both factor
analyses and examination of items of low and of high
prevalence (items ranking), 30 items were discussed in
Table 6 Factor analysis of the Major Life Changing
Decisions Profile (MLCDP): Varimax rotated matrix with
item loading (34 items)
MLCDP Items Components
1 2 3 4
Seek fertility treatment .658 .146
Study near home .639 .149 -.185
Move back to home area .603 .196 .139 .109
Not to marry or have a long term partner .594 -.168 .303
Leave college/university education early .534 .292
Move to another city .519 .125 .255 -.122
Change study subject .514 .341 -.228
Change plans for having children .504 .175
Leave school education early .496 .147
Divorce or separation from partner .486 -.134 .417
Not to buy my own home .430 .107 .386
Not to have more children .177 - .137 .167
Involved in community activities .147 .800 .147
Not to socialise .113 .749 .205
Not to go swimming .663 .273
Not to take part in sports activities .645 .275 .243
Wear different types/colour clothes/shoes .588 .206
Travel or holidays abroad .156 .578 .143
Wear make up .168 .423
Change my eating habits .381 .247
Change to different sports activities .370 .270
Select a job/career suitable for health .691
Completely change job/career .121 .134 .671 .139
Change choice of job/career .137 .650 .206
Give up job career after starting .120 .585 .507
Flexible working hours .155 .126 .584
Shorter working hours .177 .195 .483
Not to take promotion .444 .146
Move to another part of the country .148 .275
Take early retirement .700
Remain unemployed .141 .223 .575
Move my home .198 .140 .517
Not to have a sexual relationship .154 .484
Change my smoking/drinking/alcohol habits .214 .406
Extraction Method: Principal Component Analysis. Rotation Method: Varimax
with Kaiser Normalization.
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rephrased. Nine items were merged to create four new
items and four items were completely removed. Following
the scale refinement process the MLCDP items increased
from 29 to 32 items. Figures 3, 4 and 5 shows the final
draft of the MLCDP. The MLCDP score is expressed asthe absolute number of decisions that have been affected,
not as a percentage of the total number of items.
Scoring issues
We initially considered the scoring strategy from the
perspective that if a MLCD had been influenced slightly,
moderately, strongly or very strongly, then different
scores should be placed on the answer to that question.
The scores could then be added to the various questions
to give an overall score that would reflect the totality of
the strength of influence of disease on scores.
As we gained more experience with the MLCDP, our ap-
proach to the philosophy of scoring has changed. Our
current view is that what matters to a patient is whether
or not a particular major decision has or has not been
influenced by disease. Even if a decision has been
influenced only slightly, it has been influenced and so the
course of that patient’s life in relation to that decision has
been affected by their disease. We have realised that under
the graded scoring system originally proposed, if a single
decision were influenced “very strongly”, this would score,
say, 4, the same score as having four decisions influenced
“slightly”. In reality the effect of having four decisions
influenced slightly by a disease would be likely to have a
much more widespread impact than having only one deci-
sion affected by a very strong influence.
Our current view is that the total number of decisions af-
fected is the most critical information in comparing the
overall impact of having a disease on MLCDs. However we
currently retain the graded system of responses (without
scoring them) in the MLCDP because we think that this
graded information may be of value to a clinician or other
carer when counselling a patient concerning this subject.
Face validity and practicality
When the data was collected for factor analysis, all 210
patients also answered a further 6 questions to assess
the face validity and practicality of the 41-item MLCDP.
The mean time taken by the patients to complete the
MLCDP was 5.7 minutes (range = 2–15 minutes, me-
dian = 5 minutes). 204 (97.1%) patients reported that the
MLCDP was easy to complete. 198 (94.3%) patients felt
that “the response options for the statements in the
questionnaire” were straight forward. 131 (62.4%) pa-
tients reported that the instructions and statements were
“very clear” and 76 (36.2%) patients reported them as be-
ing “clear”. 181 (86%) patients considered that the
MLCDP was sufficiently comprehensive to measure the
influence of disease on important life decisions. No new
questions were suggested.
Discussion
We describe above the development and initial psycho-
metric properties of a new tool designed to measure the
Figure 1 34-item MLCDP scree plot showing the amount of variance (see Appendix).
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MLCDs. The MLCDP was directly based on the experi-
ences of patients.
The MLCDP is the first instrument specifically devel-
oped to measure the influence of chronic diseases on
MLCDs. A strict methodology [10] was followed at all
developmental stages. The MLCDP is a generic ques-
tionnaire designed to be used across all medical special-
ities. An adequate number of subjects (n = 210) from
seven medical specialities took part in the evaluation of
its initial psychometric properties. A thorough process
of multiple factor analyses was carried out. The MLCDP
is easy to understand and can be completed in less than
six minutes.
At the initial development stage a maximum possible
number of items (48) were generated from patients’ re-
sponses and grouped into six broad MLCD domains to
make sure no aspect of MLCDs was overlooked. In the
content validation of the MLCDP both quantitative and
qualitative assessment techniques were applied [15].
“Exploratory factor analysis is a complex procedure,
exacerbated by the lack of inferential statistics and the
imperfections of “real world data” [20]. The researchers’
judgment concerning the deletion and retention of spe-
cific items is important and should be based on the pa-
tients’ responses and the research concept [20]. Indeed,
the purpose of factor analysis was to see to what degree
the mathematical approach confirms clinical intuition. It
was therefore decided to keep in conceptually sound
items at this stage of the instrument development, eventhough they may have been suggested by the factor ana-
lyses to be removed. It seemed appropriate to preserve
those items for when other techniques, such as Rasch
analysis and item response theory, could be applied to
the data for further scale refinement.
At content validation stage we discussed with the panel
of judges whether it was appropriate to include MLCDs
that were confined to one particular gender or disease.
This panel had decided to exclude any MLCD category
that was reported by <5% of the patients. However the
panel retained some gender and speciality specific categor-
ies to allow them to be tested for appropriateness and rele-
vance at a later stage. The “make up” item came lowest in
the item prevalence ranking and was also suggested by
both factor analyses to be removed. But a closer consider-
ation of this item and of related comments from patients
at the scale refinement stage gave us further insight into
the importance of this MLCD. The panel discussed in
great detail the conundrum: does it really make sense to
remove an item, if it genuinely represents from the pa-
tient’s perspective an important MLCD? It was decided to
retain the “make up” item at this stage and to postpone
the decision as to whether or not to retain this item until
after Rasch analysis and Item Response Theory are applied
to MLCDP data for further scale refinement.
All the items came directly from patients and this pa-
tient origin had the paramount influence in our deci-
sions concerning the development of the scale. Another
reason to maintain items was to create a sense of con-
cordance with the respondent by ensuring that items
Table 7 29-item Major Life Changing Decisions Profile
(MLCDP) varimax rotated matrix with items loading
MLCDP Items Components
1 2 3
Not to socialise .693 .215
Involved in community activities .683 .201
Not to take part in sports activities .632 .377
Take early retirement .548 .139 -.160
Travel or holidays abroad .535 .127
Not to go swimming .534 .426
Wear different types/colour clothes/shoes .471 .344
Remain unemployed .454 .176 .126
Not to have a sexual relationship .446 .126 -.125
Change my smoking/drinking/alcohol habits .400
Move my home .322 .272
Wear make up .311 .103 .201
Seek fertility treatment .672 .153
Not to marry or have a long term partner .235 .612 -.194
Move back to home area .190 .611 .148
Study near home -.167 .599 .214
Leave college/university education early .558 .268
Divorce or separation from partner .308 .542 -.191
Move to another city .510 .280
Change study subject -.129 .499 .393
Change plans for having children .489 .197
Leave school education early .151 .467
Select a job/career suitable for health .725
Completely change job/career .143 .174 .648
Change choice of job/career .155 .181 .599
Flexible working hours .156 .589
Shorter working hours .133 .551
Give up job career after starting .398 .163 .446
Not to take promotion .129 .387
Extraction Method: Principal Component Analysis. Rotation Method: Varimax
with Kaiser Normalization.
Rotation converged in 7 iterations.
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to a “factor extraction” process. Factor analysis should
ideally be based on 300 cases, however 150 cases should
be sufficient [18] and so the sample size of 210 was con-
sidered adequate.
When deciding scoring methods and their interpret-
ation fundamental questions were raised such as what
would be the perceived “value” of a patient reporting
only one MLCD influenced by their chronic condition, if
viewed within the perspective of a score system based
on a maximum score of 32, should such a scoring sys-
tem be devised. Does the MLCDP conceptually require
any scoring system? What scoring system would assistmeaningful interpretation of the data? Two patients
reported that their disease had influenced >10 MLCDs,
indicating an extraordinary level of long-term impact on
those patients’ lives. When we consider a patient in
whom only one MLCD had been influenced, in the con-
text of the 32 items identified, it might appear that the
patient has experienced minimal impact on their life,
but even one decision recorded as being influenced was
a major decision which was life changing. There is virtu-
ally no possibility that all 32 MLCDs would be affected
in any one patient and <1% patients reported more than
10 MLCDs affected. The profile is therefore more appro-
priately scored as an absolute value rather than as a per-
centage. Therefore the fundamental unit for expressing
data from the MLCDP is the “total number of MLCDs
that have been affected”. Further psychometric analysis
will determine whether for the final scoring model a sin-
gle overall score, or a series of sub-domain scores, is
most appropriate. It remains to be determined whether
individual item weighting should be applied.
The MLCDP is not designed to detect changes over
time or to be used in follow up studies, such as before and
after intervention. It may help to identify which diseases
have the biggest impacts on patients’ lives; a total score
based on adjectival data would be difficult to interpret in
this context. However, the adjectival scoring was used for
carrying out factor analysis as part of the development
(item reduction) of the MLCDP in order to confirm
grouping of the items based on clinical intuition through
mathematical modelling. Therefore, the guidance provided
for interpretation of the scores from the adjectival system
has taken into account the reality of how the impact of a
chronic disease on MLCDs should be managed.
Factor analysis indicated that some conceptually import-
ant items, which were high in the items prevalence rank-
ing, should be deleted. However we decided that there
should be a conservative approach to deleting items at the
scale refinement stage and that decisions should be based
primarily on patients’ experiences, as shared during the
detailed interviews and postal survey responses. It was re-
assuring that nine items were suggested for removal by
two different factor analyses but it could be argued that all
41 of the original items are valid items, as they were all
suggested by at least one actual patient and therefore re-
flect patients’ reality. The tension between the outcome of
factor analysis and patients’ qualitative reports of their ex-
periences is a common phenomenon in instrumental de-
velopment. It is left to the research team to resolve this
tension through careful review of both sources.
Uses of the MLCDP
The MLCDP may be helpful to identify which diseases
have the biggest impact on patients’ lives in terms of
their MLCDs and which disease impacts most on
Figure 2 29-item MLCDP scree plot showing the amount of variance (see Appendix).
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demiological studies as a measure of disease burden.
The use of the MLCDP has the potential to compare the
influence of different diseases or diseases of different
specialties on MLCDs3-7. In the clinic, the MLCDP may
provide clinicians with a one-off insight into howTable 8 Comparison of the items deleted from the 41-item an
(MLCDP) after exploratory factor analysis
Comparison of two different EFA* Item
Common items deleted B9
C2
D7
E4
D6
E3
E5
D4
D14
Items only deleted after factor analysis of the 32-item MLCDP along
with the above 9 common items
C3
D15
D10
D1
D5
D11
E1
A2
B7
Items only deleted after factor analysis of the 41-item MLCDP along
with the above 9 common items
B10
D2
* Exploratory Factor Analysis.patients’ disease has already impacted their life decisions.
It could be used alongside a QoL questionnaire designed
to measure current impact to obtain a more complete
picture of disease impact. The MLCDP could be used in
long term cohort studies to identify how affected
MLCDs accumulate over time.d the 32-item Major Life Changing Decisions Profile
number Full description of the removed item
I decided to become self-employed
I decided not to have more children
I decided to move from one country to another
I decided to be more physically active
I wanted to move abroad but decided not to
I decided to change to different sporting activities
I decided to give up driving
I decided not to buy my own home
I wanted to wear make up but decided not to
I decided not to have any children
I decided to wear a wig/toupee
I decided to move to another part of the country
I decided to change my eating habits
I decided to move my home
I decided to wear different types/colour of clothes/shoes
I decided not to go swimming
I decided to change my study subject
I decided not to take promotion
I decided to remain unemployed
I decided to change my smoking/drinking alcohol habits
Table 9 41-item Major Life Changing Decisions Profile (MLCDP) prevalence of items ranked according to the
percentage of patients who reported them
Item number Item full description % of subjects reported Item ranking
D1 I decided to change my eating habits 71.4 1
D2 I decided to change my smoking/drinking alcohol habits 58.5 2
D3 I decided not to travel or go for holidays abroad 50.9 3
E4 I decided to be more physically active 48.5 4
E2 I decided not to take part in any sports activities 46.1 5
D12 I decided not to be involved in community activities 45.7 6
D13 I decided not to socialise 42.3 7
E1 I decided not to go swimming 40 8
B8 I decided to work shorter hours 36.1 9
D11 I decided to wear different types/colour of clothes/shoes 34.7 10
B6 I decided to select a job/career suitable for my health 30.9 11
B1 I decided to change my choice of job/career 28.5 12
E3 I decided to change to different sporting activities 27.1 13
B3 I decided to completely change my job/career 26.6 14
B4 I decided to take early retirement 24.2 15
B10 I decided to remain unemployed 23.3 16
B2 I decided to give up my job/career after starting 23.3 17
C5 I decided not to have a sexual relationship 22.3 18
D6 I wanted to move abroad but decided not to 22.3 19
B5 I decided to work flexible working hours 21.9 20
D5 I decided to move my home 19 21
C1 I decided to change my plans for when to have children 14.2 22
E5 I decided to give up driving 12.8 23
B7 I decided not to take promotion 10.4 24
C3 I decided not to have any children 10 25
A3 I decided to study near home 9.5 26
D8 I wanted to move to another city but decided not to 9 27
C2 I decided not to have more children 8 28
C6 I decided not to marry or have a long term partner 8 29
B9 I decided to become self-employed 7.6 30
C7 I decided to get divorced or separate from my partner 7.1 31
D14 I wanted to wear make up but decided not to 7.1 32
A2 I decided to change my study subject 6.6 33
D9 I decided to move back to my home area 6.1 34
D10 I decided to move to another part of the country 6.1 35
D4 I decided not to buy my own home 6.1 36
A1 I decided to leave school education early 5.7 37
A4 I decided to leave college/university education early 5.7 38
C4 I decided to seek fertility treatment 4.2 39
D7 I decided to move from one country to another 2.8 40
D15 I decided to wear a wig/toupee 0.4 41
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Table 10 Comparison of items deleted as a result of both factor analyses with item prevalence/ranking
Item deleted as a result of EFA* % Items
ranking
Full description of item
1st EFA 2nd EFA
Lowest in items prevalence ranking D15 - 0.4 41 I decided to wear a wig/toupee
D10 - 6.1 35 I decided to move to another part of the country
A2 - 6.6 33 I decided to change my study subject
D7 D7 2.8 40 I decided to move from one country to another
D4 D4 6.1 36 I decided not to buy my own home
D14 D14 7.1 32 I wanted to wear make up but decided not to
B9 B9 7.6 34 I decided to become self-employed
C2 C2 8 28 I decided not to have more children
Highest in items prevalence ranking D1 - 71.4 1 I decided to change my eating habits
E1 - 40 8 I decided not to go swimming
D11 - 34.7 10 I decided to wear different types/colour of clothes/shoes
D5 - 19 21 I decided to move my home
B7 - 10.4 24 I decided not to take promotion
C3 - 10 25 I decided not to have any children
- D2 58.5 2 I decided to change my smoking/drinking alcohol habits
- B10 23.3 16 I decided to remain unemployed
E4 E4 48.5 4 I decided to be more physically active
E3 E3 27.1 13 I decided to change to different sporting activities
D6 D6 22.3 19 I wanted to move abroad but decided not to
E5 E5 12.8 23 I decided to give up driving
* Exploratory Factor Analysis.
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This study provides a method to evaluate a critical as-
pect of the long-term impact of chronic disease on pa-
tients’ lives, the influence on MLCDs, allowing the use
of the “MLCD” domain in the assessment of long-term
disease impact and the overall assessment of HRQoL.
The MLCDP data could be used to inform health, edu-
cation and employment policies underpinned by a
patient-centred approach. The use of the MLCDP could
help with educating health providers about long-term
consequences of chronic conditions, preparing them to
help patients at an early disease stage and offer a long-
term management plan. The use of the MLCDP for epi-
demiological surveys could identify which chronic condi-
tions have the most influence on which type of MLCDs.
Limitations and further work
Further psychometric testing is required. As some items
were deleted, merged or rephrased, further factor ana-
lysis and internal consistency reliability of the remaining
items is required, followed by internal consistency reli-
ability and test-retest reliability of the final remaining
items. Full psychometric evaluation of the MLCDP
should be carried out using both the classical test theory
approach and novel techniques, such as item responsetheory. The MLCDP was not designed to detect change,
but to be used to identify the number of major life deci-
sions that a patient considers have been affected by their
disease. We would therefore not expect there to be dif-
ferences in the “behaviour” of the instrument according
to different duration of disease, but this will need to be
tested.
The current profile is not designed to detect change
over time or to be used in follow up studies, such as be-
fore and after drug intervention. Further work is required
to create a tool similar to the MLCDP that would be sensi-
tive to clinical change. The issues surrounding MLCDs are
very complex and highly subjective. There is therefore a
need to study a control group to see whether there is a dif-
ference in approach between people who have or who do
not have chronic disease and to confirm our assumption
that MLCDs are part of the normal course of life. The
MLCDP is an easy to complete generic tool. Although it
requires further validation, it provides a means to measure
this major impact of disease on patients’ lives.
Ethical approval
The study was approved by the South East Wales Local
Research Ethics committee (2nd June 2008). All partici-
pants consented to take part before starting the study.
Figure 3 The 32-items MLCDP Part 1.
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C FAMILY / RELATIONSHIPS
The following statements refer to the influence
of your chronic condition on your decisions about 
your family / relationships.
1.  I decided to change my plans for when to have children
2.  I decided not to have children
3.  I decided not to have a sexual relationship
4.  I decided not to marry or have a long term partner
5.  I decided to get divorced or separate from my partner
D SOCIAL
The following statements refer to the influence
of your chronic condition on your decisions about
your social life.
1.  I decided to change my eating habits
2. I decided to change my smoking/drinking alcohol habits
3. I decided not to travel or go for holidays abroad
4.  I decided to move
5.  I decided not to move
6.    I decided not to move abroad
7.    I decided to wear different types/colour of clothes/shoes
8.    I decided not to be involved in community activities
9.  I decided not to socialise 
10. I decided not to wear make up
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For each statement please tick one box 
Figure 4 The 32-items MLCDP Part 2.
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E PHYSICAL
The following statements refer to the influence
of your chronic condition on your decisions about
your physical aspects of life.
1. I decided not to go swimming
2. I decided not to take part in any sports activities
3. I decided to change to different sporting activities  
4. I decided to be more physically active
5. I decided to give up driving
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For each statement please tick one box 
Figure 5 The 32-items MLCDP Part 3.
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Factor analysis details
Reliability of the 41-item MLCDP
The Cronbach’s alpha reliability of the 41-item
MLCDP was 0.84, indicating good reliability. The
“corrected items-total correlation” values for 7 items
were <0.2 (not discriminating well) and therefore de-
leted, changing Cronbach’s alpha from 0.84 to 0.85. The
7 deleted items were B9 “I decided to become self-
employed”, C3 “I decided not to have any children”, D6
“I wanted to move abroad but decided not to”, D7 “I de-
cided to move from one country to another”, D15 “I de-
cided to wear a wig/toupee”, E4 “I decided to be more
physically active” and E5 “I decided to give up driving”.
Factor Analysis of 34-item MLCDP
Exploratory factor analysis of the remaining 34 items
of the MLCDP was carried out on the sample of 210
[13]. In the correlation matrix for the 34 items of the
MLCDP there were correlation coefficients r = 0.3 and
above [18] between several variables, confirming the
suitability of the data for carrying out factor analysis.
The Kaiser-Meyer-Olkin (KMO) [21,22] value was 0.73,
greater than the recommended minimum of 0.6 [18] and
Bartlett’s test of sphericity [23] was significant at p =
0.0001 confirming the sampling adequacy of the data.
Kaiser’s criterion and Cattell’s scree test statistical tech-
niques were used to determine how many factors could
be extracted.
There were 12 components with Eigenvalues >1, that
were retained for further analysis [18]. These 12 compo-
nents explained 68.6% of the variance (Table 5) [20].
The component matrix for the 34 items MLCDP showed
the loadings of 34 items on 12 components. Most of the
items loaded strongly (0.3 and above) on the first six
components and these items were considered for future
analysis. 20 items had values of >0.40.
In the scree plot [24] (Figure 1), four components were
retained for further analysis. There is a sharp drop after
the first factor indicating that the first factor accounts
for most of the variance (10.5%). Using the factor rota-
tion technique, the varimax rotated component matrix
[18] revealed that after rotation, thirty items loaded
strongly (>0.40) (Table 6) on one of the four compo-
nents, indicating a strong correlation between the item
and the corresponding components. Most items loaded
on component 1 (11), component 2 (7) and component
3 (7). Only two items failed to load on any component,
and were therefore deleted.
The four factors identified from the rotation accounted
for 38.4% of the total variance, along with their percentage
of variance explained. The first four factors accounted for
10.5%, 10.2%, 9.8% and 7.8% of the total variance
explained. After rotation, the pattern of the percentage ofvariance of individual components and their cumulative
percentage changed from the total variance explained earl-
ier. However, cumulative total variance explained (38.4%)
did not change after rotation.
To summarise this first factor analysis, in the rotated
component matrix, two items failed to load into any com-
ponent. There were two items with weak loading (<0.4)
and one item loaded on multiple components with no sig-
nificant difference in their values. These five items were
removed, leaving a 29-item MLCDP.
Factor Analysis of 29-item MLCDP
Factor analysis of the 29-item MLCDP was carried out
to see whether these remaining items fitted well together
in their components. From the scree plot examination
(Figure 2) three factors were extracted for further analysis.
This scree plot was relatively improved compared to the
previous scree plot where four factors were extracted.
Varimax rotation was applied, confirming the initial struc-
ture of the scale (Table 7). All 29 items loaded to 3
extracted components. 26 items loaded highly (0.4 and
above), 3 items loaded weakly (<0.4). Six items loaded on
two components, and for 3 of these, the values on two
components were very close (weak complex variables).
Five or more strongly loading items (0.5 or above) are de-
sirable to create a solid factor [20]. Component 1 (factor)
consisted of 12 items of which only 2 items loaded weakly
(range = 0.31 to 0.69). Component 2 consisted of 10 items
with factor loading ranging from 0.46 to 0.67, with no
weak loading. Component 3 consisted of 7 items with
loadings ranging from 0.38 to 0.72, with only one weak
loading. Total variance explained of the extracted compo-
nent, demonstrated that the 3 factors accounted for 36.5%
of the total variance. Although there were 5 more items in
the first rotation and four components were extracted,
there was not much difference compared to the percent-
age of total variance explained after the first rotation
(38.4%). The first factor accounted for the highest propor-
tion of variance, 12.7%. The second and third factors
accounted for a similar proportion of the variance, 11.9%
and 11.8% respectively.
The majority of items were close to each other in
their corresponding components. For example, compo-
nent 1 consisted of 12 items of which 9 items dealt
with MLCDs related to social and physical aspects of
patients’ lives. Six of the 29 items that weakly loaded
or had complex variables were considered for deletion,
leaving a 23-item MLCDP. Therefore as a result of fac-
tor analysis 18 MLCDP items were suggested for dele-
tion from the original 41-item MLCDP, but were
considered again at the next refinement stage of the
scale. Items which did not conceptually fit in their
extracted corresponding factors were also discussed at
this stage.
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ered in the decisions relating to retention and deletion
of items, factor analysis of the full original 41-item
MLCDP was also carried out. Items were deleted after
the final varimax rotation based on the same criteria
used for the previous analysis. The final rotated compo-
nent matrix revealed that four items failed to load on
any component, five items loaded weakly (<0.4) and two
items loaded on two components with little difference
between their values. These 11 deleted items were com-
pared with the 18 items deleted as a result of the factor
analysis of the 32-item MLCDP (Table 8). Nine of the
items were the same, which supported the initial factor
analysis approach.
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